EP4370116
AFIKAMTEN SKÖMMTUN FYRIR MEÐHÖNDLUN VIÐ TEPPANDI OFVAXTARHJARTAVÖÐVAKVILLA
Status:
EP einkaleyfi í gildi á ÍslandiEP appl. date:
15.7.2022EP published:
15.1.2025EP application number:
22753953.3
EP translation filed:
3.3.2025Grant published:
15.4.2025EPO information:
European Patent Register
Max expiry date:
14.7.2042Expiry date:
14.7.2026Next due date:
31.7.2026
Title in English:
AFICAMTEN DOSAGE REGIMENS FOR TREATING OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHYLanguage of the patent:
English
Timeline
Today
15.7.2022EP application
15.1.2025EP Publication
3.3.2025Translation submitted
15.4.2025Registration published
14.7.2026Expires
Owner
Name:
Cytokinetics, Inc.Address:
350 Oyster Point Blvd, South San Francisco CA 94080, US
Inventor
Name:
MALIK, FadyAddress:
San Francisco, California 94080, US
Name:
KUPFER, StuartAddress:
San Francisco, California 94080, US
Name:
HEITNER, Stephen B.Address:
San Francisco, California 94080, US
Name:
ROBERTSON, Laura AnnAddress:
San Francisco, California 94080, US
Name:
MENG, LixinAddress:
San Francisco, California 94080, US
Name:
OSMUKHINA, AnnaAddress:
San Francisco, California 94080, US
Name:
WOHLTMAN, QiAddress:
San Francisco, California 94080, US
Agent
Name:
Zacco Denmark A/SAddress:
Arne Jacobsens Allé 15, DK
Priority
Number:
202163203333 PDate:
16.7.2021Country:
US
Number:
202263299753 PDate:
14.1.2022Country:
US
Number:
202263305609 PDate:
1.2.2022Country:
US
Number:
202263331197 PDate:
14.4.2022Country:
US
Number:
202263343975 PDate:
19.5.2022Country:
US
Classification
Categories:
A61K 31/4245, A61K 31/4402, A61K 45/06, A61P 9/00, A61K 9/00
Annual fees
Number
Paid
Expires
Payer
Number: 4
Paid: 8.7.2025
Expires: 14.7.2026
Payer: Zacco Denmark A/S